These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18929424)

  • 1. Identification of beta-1,4-galactosyltransferase I as a target gene of HBx-induced cell cycle progression of hepatoma cell.
    Wei Y; Liu D; Zhou F; Ge Y; Xu J; Yun X; Gu J; Jiang J
    J Hepatol; 2008 Dec; 49(6):1029-37. PubMed ID: 18929424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.
    Zhang X; Dong N; Yin L; Cai N; Ma H; You J; Zhang H; Wang H; He R; Ye L
    J Med Virol; 2005 Nov; 77(3):374-81. PubMed ID: 16173017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector].
    Joo HY; Han KH; Ryu WS
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):371-80. PubMed ID: 12506241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
    Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD
    Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells.
    Zhang X; Dong N; Zhang H; You J; Wang H; Ye L
    J Lab Clin Med; 2005 Feb; 145(2):98-104. PubMed ID: 15746653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of HBV DNA replication and expression in 2.2.15 hepatoma cells infected with AFP-mediated HBX antisense RNA].
    Ma CH; Sun WS; Liu SX; Wang XY; Zhang LN; Cao YL; Han LH
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):291-4. PubMed ID: 12773245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
    Ma NF; Lau SH; Hu L; Xie D; Wu J; Yang J; Wang Y; Wu MC; Fung J; Bai X; Tzang CH; Fu L; Yang M; Su YA; Guan XY
    Clin Cancer Res; 2008 Aug; 14(16):5061-8. PubMed ID: 18698024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
    Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3.
    Yu FL; Liu HJ; Lee JW; Liao MH; Shih WL
    J Hepatol; 2005 Apr; 42(4):520-7. PubMed ID: 15763339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
    Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
    Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological effects of COOH-terminal amino acid deletions of hepatitis B virus X protein on hepatocellular carcinoma cell line Huh7].
    Liu XH; Zhu MH; Cao XZ; Zheng JM; Chen Y
    Ai Zheng; 2005 Oct; 24(10):1213-9. PubMed ID: 16219135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells.
    Chan DW; Ng IO
    J Pathol; 2006 Feb; 208(3):372-80. PubMed ID: 16353167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage.
    Xu J; Yun X; Jiang J; Wei Y; Wu Y; Zhang W; Liu Y; Wang W; Wen Y; Gu J
    Hepatology; 2010 Jul; 52(1):142-54. PubMed ID: 20578140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells.
    Liu L; Li Y; Zhang S; Yu D; Zhu M
    Oncol Rep; 2012 Jan; 27(1):168-73. PubMed ID: 21956590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells.
    You X; Liu F; Zhang T; Lv N; Liu Q; Shan C; Du Y; Kong G; Wang T; Ye L; Zhang X
    Oncogene; 2014 Jan; 33(4):449-60. PubMed ID: 23318446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition.
    Lee TK; Man K; Poon RT; Lo CM; Yuen AP; Ng IO; Ng KT; Leonard W; Fan ST
    Cancer Res; 2006 Oct; 66(20):9948-56. PubMed ID: 17047057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma cells containing hepatitis B virus X protein have enhanced invasive potential conditionally.
    Ou DP; Tao YM; Chang ZG; Tang FQ; Yang LY
    Dig Liver Dis; 2006 Apr; 38(4):262-7. PubMed ID: 16461023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.
    Arima T; Nakao K; Nakata K; Ishikawa H; Ichikawa T; Hamasaki K; Ishii N; Eguchi K
    Int J Mol Med; 2002 Apr; 9(4):397-400. PubMed ID: 11891535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.